======= ZNF675 ======= == Gene Information == * **Official Symbol**: ZNF675 * **Official Name**: zinc finger protein 675 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=171392|171392]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TD23|Q8TD23]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF675&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF675|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620090|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be involved in transcriptional regulation. May play a role during osteoclast differentiation by modulating TRAF6 signaling activity. |KRAB| |zf-C2H2| |negative regulation of interleukin-1-mediated signaling pathway| |regulation of interleukin-1-mediated signaling pathway| |negative regulation of JUN kinase activity| |negative regulation of tumor necrosis factor-mediated signaling pathway| |negative regulation of transcription regulatory region DNA binding| |bone resorption| |negative regulation of osteoclast differentiation| |negative regulation of JNK cascade| |negative regulation of stress-activated MAPK cascade| |negative regulation of stress-activated protein kinase signaling cascade| |negative regulation of myeloid leukocyte differentiation| |bone remodeling| |regulation of transcription regulatory region DNA binding| |negative regulation of DNA binding| |regulation of tumor necrosis factor-mediated signaling pathway| |negative regulation of cytokine-mediated signaling pathway| |negative regulation of response to cytokine stimulus| |regulation of osteoclast differentiation| |I-kappaB kinase/NF-kappaB signaling| |negative regulation of MAP kinase activity| |negative regulation of myeloid cell differentiation| |negative regulation of NF-kappaB transcription factor activity| |regulation of JUN kinase activity| |negative regulation of leukocyte differentiation| |tissue remodeling| |regulation of myeloid leukocyte differentiation| |regulation of DNA binding| |negative regulation of protein serine/threonine kinase activity| |negative regulation of hemopoiesis| |negative regulation of DNA-binding transcription factor activity| |regulation of cytokine-mediated signaling pathway| |negative regulation of MAPK cascade| |negative regulation of binding| |regulation of response to cytokine stimulus| |regulation of JNK cascade| |tissue homeostasis| |negative regulation of protein kinase activity| |regulation of myeloid cell differentiation| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |negative regulation of kinase activity| |regulation of leukocyte differentiation| |negative regulation of transferase activity| |ubiquitin protein ligase binding| |multicellular organismal homeostasis| |anatomical structure homeostasis| |regulation of MAP kinase activity| |regulation of binding| |negative regulation of protein phosphorylation| |regulation of DNA-binding transcription factor activity| |negative regulation of immune system process| |negative regulation of phosphorylation| |regulation of hemopoiesis| |negative regulation of intracellular signal transduction| |regulation of protein serine/threonine kinase activity| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |cytokine-mediated signaling pathway| |perinuclear region of cytoplasm| |negative regulation of cell differentiation| |regulation of cellular response to stress| |regulation of MAPK cascade| |negative regulation of catalytic activity| |regulation of protein kinase activity| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |regulation of kinase activity| |negative regulation of developmental process| |regulation of transferase activity| |cellular response to cytokine stimulus| |negative regulation of cellular protein metabolic process| |response to cytokine| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |DNA binding| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of phosphorylation| |negative regulation of response to stimulus| |homeostatic process| |regulation of immune system process| |intracellular signal transduction| |negative regulation of gene expression| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-2.03| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-2| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.79| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.85| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|1.87| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|2.04| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|2.04| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.15| |[[:results:exp16|DABN 2μM R00 exp16]]|2.28| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|2.3| ^Gene^Correlation^ |[[:human genes:r:rrn3|RRN3]]|0.426| |[[:human genes:c:chmp2a|CHMP2A]]|0.417| |[[:human genes:s:slc6a17|SLC6A17]]|0.411| |[[:human genes:c:ccna2|CCNA2]]|0.408| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.405| |[[:human genes:r:rrp15|RRP15]]|0.404| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2339 * **Expression level (log2 read counts)**: 5.58 {{:chemogenomics:nalm6 dist.png?nolink |}}